Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;15(11):1258-9.
doi: 10.1016/S1473-3099(15)00375-8.

Ebola: Europe-Africa research collaborations

Peter William Horby  1 , Hubert Endzt, Jean-Jacques Muyembe-Tamfum  2 , Johan van Griensven  3 , Sahr Gevao  4 , Herman Goossens  5 , Denis Malvy, Niankoye Yves Haba  6 , Yazdan Yazdanpanah  7 , Piero Olliaro  8 , Calum Semple  9 , Menno de Jong  10 , Alexandre Delamou  11 , Trudie Lang  12 , Gail Carson  13 , Stephen B Kennedy
Affiliations

Ebola: Europe-Africa research collaborations

Peter William Horby et al. Lancet Infect Dis. 2015 Nov.

Erratum in

  • Corrections.
    [No authors listed] [No authors listed] Lancet Infect Dis. 2015 Dec;15(12):1375. doi: 10.1016/S1473-3099(15)00432-6. Epub 2015 Nov 16. Lancet Infect Dis. 2015. PMID: 26607118 No abstract available.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment in

  • Non-randomised Ebola trials--lessons for optimal outbreak research.
    Ippolito G, Lanini S, Brouqui P, Di Caro A, Vairo F, Fusco FM, Krishna S, Capobianchi MR, Kyobe-Bosa H, Puro V, Wölfel R, Avsic-Zupanc T, Ioannidis JP, Portella G, Kremsner P, Dar O, Bates M, Zumla A. Ippolito G, et al. Lancet Infect Dis. 2016 Apr;16(4):407-8. doi: 10.1016/S1473-3099(16)00132-8. Lancet Infect Dis. 2016. PMID: 27036341 No abstract available.

References

    1. Ippolito G, Lanini S, Brouqui P, et al. Ebola: missed opportunities for Europe–Africa research. Lancet Infect Dis. 2015;15:1254–55. - PubMed
    1. Agnandji ST, Huttner A, Zinser ME, et al. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe—preliminary report. N Engl J Med. 2015 doi: 10.1056/NEJMoa1502924. published online April 1. - DOI - PMC - PubMed
    1. University of Oxford press release. Trials of an experimental Ebola virus vaccine progress at speed. [accessed Oct 5, 2015];2014 Nov 17; http://www.ox.ac.uk/news/2014-11-17-trials-experimental-ebola-vaccine-pr....
    1. Henao-Restrepo AM, Longini IM, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386:857–66. - PubMed
    1. Sissoko D, Folkesson E, Abdoul M, et al. Favipiravir in patients with Ebola virus disease: early results of the JIKI trial in Guinea. Conference on Retroviruses and Opportunistic Infections; Boston, MA. Feb 22–25, 2016; Abstract 103-ALB.

MeSH terms